Ihab Darwish

Person

San Carlos, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
TGF-β inhibitors
- Patent number 12,227,508
- Issue date Feb 18, 2025
- Rigel Pharmaceuticals, Inc.
- Marina Gelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1K inhibitors
- Patent number 12,043,629
- Issue date Jul 23, 2024
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 12,006,314
- Issue date Jun 11, 2024
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,919,890
- Issue date Mar 5, 2024
- Eli Lilly and Company
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer nuclear hormone receptor-targeting compounds
- Patent number 11,834,458
- Issue date Dec 5, 2023
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 11,672,791
- Issue date Jun 13, 2023
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1K inhibitors
- Patent number 11,667,643
- Issue date Jun 6, 2023
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1K inhibitors
- Patent number 11,584,758
- Issue date Feb 21, 2023
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic RIP1 inhibitory compounds
- Patent number 11,578,078
- Issue date Feb 14, 2023
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,564,930
- Issue date Jan 31, 2023
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 11,466,018
- Issue date Oct 11, 2022
- Rigel Pharmaceuticals, Inc.
- Marina Gelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,407,736
- Issue date Aug 9, 2022
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazole compounds, formulations thereof, and a method for using th...
- Patent number 11,370,787
- Issue date Jun 28, 2022
- Rigel Pharmaceuticals, Inc.
- Lu Chou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-beta inhibitors
- Patent number 11,352,360
- Issue date Jun 7, 2022
- Rigel Pharmaceuticals, hic.
- Todd Kinsella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fumarate analogs and uses thereof
- Patent number 11,129,819
- Issue date Sep 28, 2021
- Rigel Pharmaceuticals, Inc.
- Matthew Duncton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 11,110,082
- Issue date Sep 7, 2021
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 10,975,064
- Issue date Apr 13, 2021
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of Nrf2 activating compounds and uses thereof
- Patent number 10,889,562
- Issue date Jan 12, 2021
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 10,851,093
- Issue date Dec 1, 2020
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitorC
- Patent number 10,822,337
- Issue date Nov 3, 2020
- Rigel Pharmaceuticals, Inc.
- Marina Gelman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of NRF2 activating compounds and uses thereof
- Patent number 10,774,066
- Issue date Sep 15, 2020
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazole derivatives as TGF-beta inhibitors
- Patent number 10,696,693
- Issue date Jun 30, 2020
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fumarate analogs and uses thereof
- Patent number 10,493,066
- Issue date Dec 3, 2019
- Rigel Pharmaceuticals, Inc.
- Matthew Duncton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 10,434,096
- Issue date Oct 8, 2019
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 10,287,295
- Issue date May 14, 2019
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 10,130,623
- Issue date Nov 20, 2018
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF-beta inhibitors
- Patent number 9,884,868
- Issue date Feb 6, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fumarate analogs and uses thereof
- Patent number 9,801,866
- Issue date Oct 31, 2017
- Rigl Pharmaceutical, Inc.
- Matthew Duncton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kin...
- Patent number 9,624,229
- Issue date Apr 18, 2017
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fumarate analogs and uses thereof
- Patent number 9,475,781
- Issue date Oct 25, 2016
- Rigel Pharmaceuticals, Inc.
- Matthew Duncton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS
- Publication number 20250092057
- Publication date Mar 20, 2025
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20240368119
- Publication date Nov 7, 2024
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20240352027
- Publication date Oct 24, 2024
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20240217958
- Publication date Jul 4, 2024
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...
- Publication number 20230399326
- Publication date Dec 14, 2023
- Rigel Pharmaceuticals, Inc.
- Lu Chou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC IRAK INHIBITORS
- Publication number 20230312568
- Publication date Oct 5, 2023
- Rigel Pharmaceuticals, Inc.
- Zhushou Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20230310454
- Publication date Oct 5, 2023
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1K INHIBITORS
- Publication number 20230265100
- Publication date Aug 24, 2023
- Rigel Pharmaceuticals, Inc.
- Somasekhar BHAMIDIPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1K INHIBITORS
- Publication number 20230227469
- Publication date Jul 20, 2023
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS
- Publication number 20230143161
- Publication date May 11, 2023
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-ß INHIBITORS
- Publication number 20230123591
- Publication date Apr 20, 2023
- Rigel Pharmaceuticals, Inc.
- Marina Gelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20230112865
- Publication date Apr 13, 2023
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20230012676
- Publication date Jan 19, 2023
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
- Publication number 20220340587
- Publication date Oct 27, 2022
- NUVATION BIO INC.
- David Hung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...
- Publication number 20220306620
- Publication date Sep 29, 2022
- Rigel Pharmaceuticals, Inc.
- Lu Chou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUN...
- Publication number 20220288047
- Publication date Sep 15, 2022
- Rigel Pharmaceuticals, Inc.
- Lu Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1K INHIBITORS
- Publication number 20220009936
- Publication date Jan 13, 2022
- Rigel Pharmaceuticals, Inc.
- Somasekhar BHMIDIPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1K INHIBITORS
- Publication number 20210317135
- Publication date Oct 14, 2021
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210214347
- Publication date Jul 15, 2021
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS
- Publication number 20210139494
- Publication date May 13, 2021
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-ß INHIBITORS
- Publication number 20210130361
- Publication date May 6, 2021
- Rigel Pharmaceuticals, Inc.
- Marina Gelman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20210078990
- Publication date Mar 18, 2021
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210069208
- Publication date Mar 11, 2021
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210070743
- Publication date Mar 11, 2021
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...
- Publication number 20210061798
- Publication date Mar 4, 2021
- Rigel Pharmaceuticals, Inc.
- Lu Chou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prodrugs of Nrf2 Activating Compounds and Uses Thereof
- Publication number 20200369644
- Publication date Nov 26, 2020
- Rigel Pharmaceuticals, Inc.
- Jiaxin Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fumarate Analogs and Uses Thereof
- Publication number 20200155531
- Publication date May 21, 2020
- Rigel Pharmaceuticals, Inc.
- Matthew Duncton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20200078348
- Publication date Mar 12, 2020
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20200031832
- Publication date Jan 30, 2020
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tyrosine Kinase Inhibitors
- Publication number 20190382395
- Publication date Dec 19, 2019
- Rigel Pharmaceuticals, Inc.
- Ihab Darwish
- C07 - ORGANIC CHEMISTRY

Ihab Darwish

Person

Patents Grantslast 30 patents

TGF-β inhibitors

RIP1K inhibitors

Anti-cancer nuclear hormone receptor-targeting compounds

RIP1 inhibitory compounds and methods for making and using the same

Anti-cancer nuclear hormone receptor-targeting compounds

Tyrosine kinase inhibitors

RIP1K inhibitors

RIP1K inhibitors

Heterocyclic RIP1 inhibitory compounds

RIP1 inhibitory compounds and methods for making and using the same

TGF-β inhibitors

RIP1 inhibitory compounds and methods for making and using the same

Pyrazole compounds, formulations thereof, and a method for using th...

TGF-beta inhibitors

Fumarate analogs and uses thereof

Tyrosine kinase inhibitors

RIP1 inhibitory compounds and methods for making and using the same

Prodrugs of Nrf2 activating compounds and uses thereof

Tyrosine kinase inhibitors

TGF-β inhibitorC

Prodrugs of NRF2 activating compounds and uses thereof

Fused imidazole derivatives as TGF-beta inhibitors

Fumarate analogs and uses thereof

Tyrosine kinase inhibitors

TGF-β inhibitors

Tyrosine kinase inhibitors

TGF-beta inhibitors

Fumarate analogs and uses thereof

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kin...

Fumarate analogs and uses thereof

Patents Applicationslast 30 patents

HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...

TRICYCLIC IRAK INHIBITORS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1K INHIBITORS

RIP1K INHIBITORS

HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS

TGF-ß INHIBITORS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

TYROSINE KINASE INHIBITORS

ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS

PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...

METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUN...

RIP1K INHIBITORS

RIP1K INHIBITORS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS

TGF-ß INHIBITORS

TYROSINE KINASE INHIBITORS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING TH...

Prodrugs of Nrf2 Activating Compounds and Uses Thereof

Fumarate Analogs and Uses Thereof

TYROSINE KINASE INHIBITORS

TGF-Beta Inhibitors

Tyrosine Kinase Inhibitors